"Scott & Christie Eyecare Associates is an extension of the ophthalmology practice of the late Dorothy Christie Scott, MD. Dr. Scott was a pioneer in the field, becoming one of only a few female ophthalmologists in the Pittsburgh area when she began her practice in 1958. William C. Christie, MD, acquired Dr. Scott’s practice on July 1, 1990, and incorporated shortly thereafter as Scott & Christie Eyecare Associates, PC. We currently offer services at offices located in Fox Chapel and Cranberry Township. In addition to those locations, Scott & Christie Eyecare Associates is affiliated with the Surgery Center at Cranberry."

During the past decade, Scott & Christie and Associates, PC conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 19 clinical trials were completed, i.e. on average, 70.4% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 15 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Scott & Christie and Associates, PC" #1 sponsor was "Allergan" with 6 trials, followed by "Abbott Medical Optics" with 5 trials sponsored, "Santen Inc." with 4 trials sponsored, "Aerie Pharmaceuticals" with 2 trials sponsored and "Johnson & Johnson Surgical Vision, Inc." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Scott & Christie and Associates, PC" #1 collaborator was "Daewoong Pharmaceutical Co. LTD." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Scott & Christie and Associates, PC" are "Cataract" (7 trials), "Ocular Hypertension" (4 trials), "Dry Eye Disease" (3 trials), "Dry Eye Syndromes" (3 trials) and "Presbyopia" (3 trials). Many other conditions were trialed in "Scott & Christie and Associates, PC" in a lesser frequency.

Most popular intervention types in "Scott & Christie and Associates, PC" are "Drug" (22 trials), "Device" (7 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "AGN-190584 ophthalmic solution" (2 trials), "AGN-199201 ophthalmic solution" (2 trials), "Bimatoprost SR" (2 trials) and "DE-117 Ophthalmic Solution" (2 trials). Other intervention names were less common.

The vast majority of trials in "Scott & Christie and Associates, PC" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Scott & Christie and Associates, PC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Scott & Christie and Associates, PC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Scott & Christie and Associates, PC, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".